These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 9989666)

  • 1. A rapid and simple detection of genetic defects responsible for the phenotypic polymorphism of cytochrome P450 2C19.
    Itoh K; Inoue K; Yanagiwara S; Kyoya H; Suzuki T
    Biol Pharm Bull; 1999 Jan; 22(1):77-9. PubMed ID: 9989666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese.
    De Morais SM; Wilkinson GR; Blaisdell J; Meyer UA; Nakamura K; Goldstein JA
    Mol Pharmacol; 1994 Oct; 46(4):594-8. PubMed ID: 7969038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymerase chain reaction-single-strand conformation polymorphism based determination of two major genetic defects responsible for a phenotypic polymorphism of cytochrome P450 (CYP) 2C19 in the Japanese population.
    Itoh K; Inoue K; Nakao H; Yanagiwara S; Tada H; Suzuki T
    Anal Biochem; 2000 Aug; 284(1):160-2. PubMed ID: 10933870
    [No Abstract]   [Full Text] [Related]  

  • 4. Linkage of mutant alleles of CYP2C18 and CYP2C19 in a Japanese population.
    Kubota T; Hibi N; Chiba K
    Biochem Pharmacol; 1998 Jun; 55(12):2039-42. PubMed ID: 9714325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that poor metabolizers of (S)-mephenytoin could be identified by haplotypes of CYP2C19 in Japanese.
    Takakubo F; Kuwano A; Kondo I
    Pharmacogenetics; 1996 Jun; 6(3):265-7. PubMed ID: 8807668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphism analysis of cytochrome P4502C19 in Chinese Uigur and Han populations.
    Niu CY; Luo JY; Hao ZM
    Chin J Dig Dis; 2004; 5(2):76-80. PubMed ID: 15612662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphism of CYP2C19 and lansoprazole pharmacokinetics in Japanese subjects.
    Katsuki H; Nakamura C; Arimori K; Fujiyama S; Nakano M
    Eur J Clin Pharmacol; 1997; 52(5):391-6. PubMed ID: 9272410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the incidence of the CYP2C19 polymorphism affecting the S-mephenytoin phenotype in Chinese Han and Bai populations and identification of a new rare CYP2C19 mutant allele.
    Xiao ZS; Goldstein JA; Xie HG; Blaisdell J; Wang W; Jiang CH; Yan FX; He N; Huang SL; Xu ZH; Zhou HH
    J Pharmacol Exp Ther; 1997 Apr; 281(1):604-9. PubMed ID: 9103550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The molecular mechanism of polymorphism of S-mephenytoin hydroxylative metabolism].
    Lou YQ; Kuang TY
    Sheng Li Ke Xue Jin Zhan; 1995 Jan; 26(1):23-8. PubMed ID: 7604218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the CYP2C19 polymorphism in a North-eastern Thai population.
    Tassaneeyakul W; Tawalee A; Tassaneeyakul W; Kukongviriyapan V; Blaisdell J; Goldstein JA; Gaysornsiri D
    Pharmacogenetics; 2002 Apr; 12(3):221-5. PubMed ID: 11927837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequencies of the defective CYP2C19 alleles responsible for the mephenytoin poor metabolizer phenotype in various Oriental, Caucasian, Saudi Arabian and American black populations.
    Goldstein JA; Ishizaki T; Chiba K; de Morais SM; Bell D; Krahn PM; Evans DA
    Pharmacogenetics; 1997 Feb; 7(1):59-64. PubMed ID: 9110363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotyping of S-mephenytoin 4'-hydroxylation in an extended Japanese population.
    Kubota T; Chiba K; Ishizaki T
    Clin Pharmacol Ther; 1996 Dec; 60(6):661-6. PubMed ID: 8988068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic analysis of the S-mephenytoin polymorphism in a Chinese population.
    de Morais SM; Goldstein JA; Xie HG; Huang SL; Lu YQ; Xia H; Xiao ZS; Ile N; Zhou HH
    Clin Pharmacol Ther; 1995 Oct; 58(4):404-11. PubMed ID: 7586932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotype analysis of the CYP2C19 gene in HCV-seropositive patients with cirrhosis and hepatocellular carcinoma.
    Chau TK; Marakami S; Kawai B; Nasu K; Kubota T; Ohnishi A
    Life Sci; 2000 Aug; 67(14):1719-24. PubMed ID: 11021356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cure of refractory duodenal ulcer and infection caused by Helicobacter pylori by high doses of omeprazole and amoxicillin in a homozygous CYP2C19 extensive metabolizer patient.
    Furuta T; Takashima M; Shirai N; Xiao F; Hanai H; Ohashi K; Ishizaki T
    Clin Pharmacol Ther; 2000 Jun; 67(6):684-9. PubMed ID: 10872651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel transversion in the intron 5 donor splice junction of CYP2C19 and a sequence polymorphism in exon 3 contribute to the poor metabolizer phenotype for the anticonvulsant drug S-mephenytoin.
    Ibeanu GC; Blaisdell J; Ferguson RJ; Ghanayem BI; Brosen K; Benhamou S; Bouchardy C; Wilkinson GR; Dayer P; Goldstein JA
    J Pharmacol Exp Ther; 1999 Aug; 290(2):635-40. PubMed ID: 10411572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linkage between the distribution of mutations in the CYP2C18 and CYP2C19 genes in the Japanese and Caucasian.
    Inoue K; Yamazaki H; Shimada T
    Xenobiotica; 1998 Apr; 28(4):403-11. PubMed ID: 9604303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A discordance of the cytochrome P450 2C19 genotype and phenotype in patients with advanced cancer.
    Williams ML; Bhargava P; Cherrouk I; Marshall JL; Flockhart DA; Wainer IW
    Br J Clin Pharmacol; 2000 May; 49(5):485-8. PubMed ID: 10792207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytochrome P450 2C19 gene polymorphism in four Chinese nationality populations].
    Zhang S; Dong Z; Tang L; Zhou Q; Wu Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Feb; 19(1):52-4. PubMed ID: 11836688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of polymorphisms in the cytochrome P450 (CYP) 2C19 and 2C18 genes in Japanese epileptic patients.
    Mamiya K; Ieiri I; Miyahara S; Imai J; Furuumi H; Fukumaki Y; Ninomiya H; Tashiro N; Yamada H; Higuchi S
    Pharmacogenetics; 1998 Feb; 8(1):87-90. PubMed ID: 9511186
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.